lomustine has been researched along with Blindness in 2 studies
Blindness: The inability to see or the loss or absence of perception of visual stimuli. This condition may be the result of EYE DISEASES; OPTIC NERVE DISEASES; OPTIC CHIASM diseases; or BRAIN DISEASES affecting the VISUAL PATHWAYS or OCCIPITAL LOBE.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The radiation dose ranged from 3000 to 4650 rad and the oral CCNU dosage from 300 mg to 1050 mg." | 1.27 | Sudden onset of blindness in patients treated with oral CCNU and low-dose cranial irradiation. ( Kleinschmidt-Demasters, BK; Perez, GM; Wilson, WB, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schornagel, JH | 1 |
| Verweij, J | 1 |
| de Mulder, PH | 1 |
| Wildiers, J | 1 |
| Kirkpatrick, A | 1 |
| Cognetti, F | 1 |
| Wilson, WB | 1 |
| Perez, GM | 1 |
| Kleinschmidt-Demasters, BK | 1 |
2 other studies available for lomustine and Blindness
| Article | Year |
|---|---|
Acute blindness during treatment of recurrent or metastatic nasopharyngeal carcinoma with doxorubicin and CCNU.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blindness; Doxorubicin; Drug Evaluation | 1990 |
Sudden onset of blindness in patients treated with oral CCNU and low-dose cranial irradiation.
Topics: Administration, Oral; Aged; Blindness; Brain; Brain Neoplasms; Carcinoma, Small Cell; Combined Modal | 1987 |